HTG Molecular Diagnostics Inc
Diagnostics & Research
Healthcare
HTGM
133 M shares
NASDAQ US
traded
05 Jun 2023
listed
yes
open
2.11
52 week high
6.45
high
2.25
52 week low
1.33
low
1.54
growth
9.09 %
previous Close
2.12
P/E ratio
-0
market cap
3.47 M
div yield
0
usd
Sep 2022
qoq
revenue
1.25 M
0.00 %
net incoming
-4.52 M
0.00 %
eps
-4.92 %
-811.11 %
eps surprise
23.36 %
net profit margin
-361.04 %
-361.00 %
operating incoming
-4.35 M
0.00 %
net change in cash
-2.54 M
0.00 %
cash on hand
3.21 M
0.00 %
cost of revenue
671 K
0.00 %
top top